25 XP   0   0   10

Biotron Ltd
Buy, Hold or Sell?

Let's analyse Biotron together

PenkeI guess you are interested in Biotron Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biotron Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biotron Ltd

I send you an email if I find something interesting about Biotron Ltd.

Quick analysis of Biotron (30 sec.)










What can you expect buying and holding a share of Biotron? (30 sec.)

How much money do you get?

How much money do you get?
A$0.01
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$0.01
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$0.03
Return On Investment
44.9%

For what price can you sell your share?

Current Price per Share
A$0.07
Expected price per share
A$0.068 - A$0.087
How sure are you?
50%

1. Valuation of Biotron (5 min.)




Live pricePrice per Share (EOD)

A$0.07

Intrinsic Value Per Share

A$-0.04 - A$-0.03

Total Value Per Share

A$-0.03 - A$-0.02

2. Growth of Biotron (5 min.)




Is Biotron growing?

Current yearPrevious yearGrowGrow %
How rich?$2m$701.7k$1.3m65.6%

How much money is Biotron making?

Current yearPrevious yearGrowGrow %
Making money-$2.2m-$1.7m-$457.1k-20.4%
Net Profit Margin-244.0%-178.4%--

How much money comes from the company's main activities?

3. Financial Health of Biotron (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of Biotron? (5 min.)

Welcome investor! Biotron's management wants to use your money to grow the business. In return you get a share of Biotron.

What can you expect buying and holding a share of Biotron?

First you should know what it really means to hold a share of Biotron. And how you can make/lose money.

Speculation

The Price per Share of Biotron is A$0.071. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biotron.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biotron, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biotron.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-3.5%0.00-3.5%0.00-2.8%0.00-2.9%0.00-2.8%
Usd Book Value Change Per Share0.002.1%0.002.1%0.00-2.8%0.000.4%0.00-0.1%
Usd Dividend Per Share0.005.1%0.005.1%0.000.0%0.002.0%0.001.0%
Usd Total Gains Per Share0.017.2%0.017.2%0.00-2.8%0.002.4%0.000.9%
Usd Price Per Share0.02-0.02-0.04-0.03-0.03-
Price to Earnings Ratio-6.72--6.72--19.17--18.52--18.21-
Price-to-Total Gains Ratio3.26-3.26--19.25--1.00--15.40-
Price to Book Ratio7.39-7.39-48.81-17.34-20.17-
Price-to-Total Gains Ratio3.26-3.26--19.25--1.00--15.40-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0456033
Number of shares21928
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.010.00
Gains per Quarter (21928 shares)112.1636.60
Gains per Year (21928 shares)448.65146.41
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
131913043912324136
263826088824647282
3956390133736871428
41275520178649194574
515946492235614118720
619137792684737142866
7223190931338601651012
82550103935829821891158
928691169403111052131304
1031881299448012282361450

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.022.02.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%3.02.00.060.0%4.06.00.040.0%10.014.00.041.7%
Dividend per Share1.00.00.0100.0%1.00.02.033.3%2.00.03.040.0%2.00.08.020.0%2.00.022.08.3%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%3.02.00.060.0%4.06.00.040.0%10.014.00.041.7%

Fundamentals of Biotron

About Biotron Ltd

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-04-13 07:35:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Biotron Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biotron earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biotron to the Biotechnology industry mean.
  • A Net Profit Margin of -244.0% means that $-2.44 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biotron Ltd:

  • The MRQ is -244.0%. The company is making a huge loss. -2
  • The TTM is -244.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-244.0%TTM-244.0%0.0%
TTM-244.0%YOY-178.4%-65.6%
TTM-244.0%5Y-397.2%+153.2%
5Y-397.2%10Y-17,388.4%+16,991.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-244.0%-197.2%-46.8%
TTM-244.0%-210.4%-33.6%
YOY-178.4%-279.3%+100.9%
5Y-397.2%-436.8%+39.6%
10Y-17,388.4%-599.3%-16,789.1%
1.1.2. Return on Assets

Shows how efficient Biotron is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biotron to the Biotechnology industry mean.
  • -84.5% Return on Assets means that Biotron generated $-0.84 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biotron Ltd:

  • The MRQ is -84.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -84.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-84.5%TTM-84.5%0.0%
TTM-84.5%YOY-145.9%+61.4%
TTM-84.5%5Y-71.5%-12.9%
5Y-71.5%10Y-91.7%+20.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-84.5%-13.6%-70.9%
TTM-84.5%-12.9%-71.6%
YOY-145.9%-11.9%-134.0%
5Y-71.5%-14.2%-57.3%
10Y-91.7%-16.2%-75.5%
1.1.3. Return on Equity

Shows how efficient Biotron is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biotron to the Biotechnology industry mean.
  • -110.1% Return on Equity means Biotron generated $-1.10 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biotron Ltd:

  • The MRQ is -110.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -110.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-110.1%TTM-110.1%0.0%
TTM-110.1%YOY-254.6%+144.5%
TTM-110.1%5Y-101.4%-8.7%
5Y-101.4%10Y-123.0%+21.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-110.1%-17.0%-93.1%
TTM-110.1%-16.1%-94.0%
YOY-254.6%-15.4%-239.2%
5Y-101.4%-20.0%-81.4%
10Y-123.0%-21.1%-101.9%

1.2. Operating Efficiency of Biotron Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biotron is operating .

  • Measures how much profit Biotron makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biotron to the Biotechnology industry mean.
  • An Operating Margin of -352.0% means the company generated $-3.52  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biotron Ltd:

  • The MRQ is -352.0%. The company is operating very inefficient. -2
  • The TTM is -352.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-352.0%TTM-352.0%0.0%
TTM-352.0%YOY-178.3%-173.7%
TTM-352.0%5Y-1,375.5%+1,023.4%
5Y-1,375.5%10Y-17,918.9%+16,543.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-352.0%-286.1%-65.9%
TTM-352.0%-224.4%-127.6%
YOY-178.3%-288.4%+110.1%
5Y-1,375.5%-475.2%-900.3%
10Y-17,918.9%-624.7%-17,294.2%
1.2.2. Operating Ratio

Measures how efficient Biotron is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.52 means that the operating costs are $3.52 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biotron Ltd:

  • The MRQ is 3.520. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.520. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.520TTM3.5200.000
TTM3.520YOY1.783+1.737
TTM3.5205Y18.218-14.698
5Y18.21810Y539.862-521.644
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5202.997+0.523
TTM3.5203.247+0.273
YOY1.7833.766-1.983
5Y18.2185.675+12.543
10Y539.8627.857+532.005

1.3. Liquidity of Biotron Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biotron is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.22 means the company has $4.22 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biotron Ltd:

  • The MRQ is 4.218. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.218. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.218TTM4.2180.000
TTM4.218YOY2.348+1.870
TTM4.2185Y7.842-3.624
5Y7.84210Y7.063+0.779
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2183.930+0.288
TTM4.2184.251-0.033
YOY2.3485.436-3.088
5Y7.8426.045+1.797
10Y7.0636.363+0.700
1.3.2. Quick Ratio

Measures if Biotron is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biotron to the Biotechnology industry mean.
  • A Quick Ratio of 4.19 means the company can pay off $4.19 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biotron Ltd:

  • The MRQ is 4.193. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.193. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.193TTM4.1930.000
TTM4.193YOY2.320+1.873
TTM4.1935Y7.777-3.584
5Y7.77710Y6.983+0.794
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1933.629+0.564
TTM4.1934.065+0.128
YOY2.3205.397-3.077
5Y7.7775.993+1.784
10Y6.9836.277+0.706

1.4. Solvency of Biotron Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biotron assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biotron to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.23 means that Biotron assets are financed with 23.3% credit (debt) and the remaining percentage (100% - 23.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biotron Ltd:

  • The MRQ is 0.233. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.233. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.233TTM0.2330.000
TTM0.233YOY0.427-0.194
TTM0.2335Y0.189+0.043
5Y0.18910Y0.191-0.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2330.332-0.099
TTM0.2330.334-0.101
YOY0.4270.268+0.159
5Y0.1890.366-0.177
10Y0.1910.390-0.199
1.4.2. Debt to Equity Ratio

Measures if Biotron is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biotron to the Biotechnology industry mean.
  • A Debt to Equity ratio of 30.3% means that company has $0.30 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biotron Ltd:

  • The MRQ is 0.303. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.303. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.303TTM0.3030.000
TTM0.303YOY0.745-0.441
TTM0.3035Y0.273+0.030
5Y0.27310Y0.263+0.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3030.381-0.078
TTM0.3030.390-0.087
YOY0.7450.334+0.411
5Y0.2730.434-0.161
10Y0.2630.466-0.203

2. Market Valuation of Biotron Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biotron generates.

  • Above 15 is considered overpriced but always compare Biotron to the Biotechnology industry mean.
  • A PE ratio of -6.72 means the investor is paying $-6.72 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biotron Ltd:

  • The EOD is -18.341. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.716. Based on the earnings, the company is expensive. -2
  • The TTM is -6.716. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-18.341MRQ-6.716-11.625
MRQ-6.716TTM-6.7160.000
TTM-6.716YOY-19.174+12.458
TTM-6.7165Y-18.521+11.804
5Y-18.52110Y-18.213-0.308
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-18.341-2.315-16.026
MRQ-6.716-2.560-4.156
TTM-6.716-2.664-4.052
YOY-19.174-4.122-15.052
5Y-18.521-6.258-12.263
10Y-18.213-6.108-12.105
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biotron Ltd:

  • The EOD is -19.471. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.130. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.130. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.471MRQ-7.130-12.341
MRQ-7.130TTM-7.1300.000
TTM-7.130YOY-21.890+14.759
TTM-7.1305Y-19.901+12.771
5Y-19.90110Y-18.820-1.082
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-19.471-3.067-16.404
MRQ-7.130-3.251-3.879
TTM-7.130-3.545-3.585
YOY-21.890-5.595-16.295
5Y-19.901-8.315-11.586
10Y-18.820-8.708-10.112
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biotron is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 7.39 means the investor is paying $7.39 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biotron Ltd:

  • The EOD is 20.192. Based on the equity, the company is expensive. -2
  • The MRQ is 7.394. Based on the equity, the company is overpriced. -1
  • The TTM is 7.394. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD20.192MRQ7.394+12.798
MRQ7.394TTM7.3940.000
TTM7.394YOY48.810-41.416
TTM7.3945Y17.342-9.948
5Y17.34210Y20.167-2.825
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD20.1921.905+18.287
MRQ7.3942.111+5.283
TTM7.3942.095+5.299
YOY48.8102.836+45.974
5Y17.3423.443+13.899
10Y20.1673.794+16.373
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biotron Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Biotron Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0020.0020%-0.003+233%0.000+450%0.000+106%
Book Value Per Share--0.0040.0040%0.001+190%0.005-23%0.004-1%
Current Ratio--4.2184.2180%2.348+80%7.842-46%7.063-40%
Debt To Asset Ratio--0.2330.2330%0.427-45%0.189+23%0.191+22%
Debt To Equity Ratio--0.3030.3030%0.745-59%0.273+11%0.263+15%
Dividend Per Share--0.0060.0060%-+100%0.002+160%0.001+419%
Eps---0.004-0.0040%-0.003-20%-0.003-16%-0.003-19%
Free Cash Flow Per Share---0.004-0.0040%-0.003-26%-0.003-16%-0.003-17%
Free Cash Flow To Equity Per Share--0.0020.0020%-0.003+210%0.001+357%0.001+381%
Gross Profit Margin--1.2661.2660%1.319-4%1.224+3%1.112+14%
Intrinsic Value_10Y_max---0.027--------
Intrinsic Value_10Y_min---0.037--------
Intrinsic Value_1Y_max---0.003--------
Intrinsic Value_1Y_min---0.003--------
Intrinsic Value_3Y_max---0.009--------
Intrinsic Value_3Y_min---0.011--------
Intrinsic Value_5Y_max---0.014--------
Intrinsic Value_5Y_min---0.018--------
Market Cap64061593.728+63%23459175.16823459175.1680%53324509.709-56%48037172.536-51%48713879.512-52%
Net Profit Margin---2.440-2.4400%-1.784-27%-3.972+63%-173.884+7026%
Operating Margin---3.520-3.5200%-1.783-49%-13.755+291%-179.189+4990%
Operating Ratio--3.5203.5200%1.783+97%18.218-81%539.862-99%
Pb Ratio20.192+63%7.3947.3940%48.810-85%17.342-57%20.167-63%
Pe Ratio-18.341-173%-6.716-6.7160%-19.174+185%-18.521+176%-18.213+171%
Price Per Share0.071+63%0.0260.0260%0.059-56%0.053-51%0.054-52%
Price To Free Cash Flow Ratio-19.471-173%-7.130-7.1300%-21.890+207%-19.901+179%-18.820+164%
Price To Total Gains Ratio8.916+63%3.2653.2650%-19.247+690%-0.997+131%-15.401+572%
Quick Ratio--4.1934.1930%2.320+81%7.777-46%6.983-40%
Return On Assets---0.845-0.8450%-1.459+73%-0.715-15%-0.917+9%
Return On Equity---1.101-1.1010%-2.546+131%-1.014-8%-1.230+12%
Total Gains Per Share--0.0080.0080%-0.003+139%0.003+206%0.001+742%
Usd Book Value--2037796.9492037796.9490%701710.181+190%2638584.329-23%2050929.479-1%
Usd Book Value Change Per Share--0.0010.0010%-0.002+233%0.000+450%0.000+106%
Usd Book Value Per Share--0.0020.0020%0.001+190%0.003-23%0.002-1%
Usd Dividend Per Share--0.0040.0040%-+100%0.001+160%0.001+419%
Usd Eps---0.002-0.0020%-0.002-20%-0.002-16%-0.002-19%
Usd Free Cash Flow---2113189.481-2113189.4810%-1564673.630-26%-1767615.895-16%-1751852.504-17%
Usd Free Cash Flow Per Share---0.002-0.0020%-0.002-26%-0.002-16%-0.002-17%
Usd Free Cash Flow To Equity Per Share--0.0020.0020%-0.002+210%0.000+357%0.000+381%
Usd Market Cap41146761.651+63%15067828.21015067828.2100%34250332.586-56%30854275.920-51%31288924.811-52%
Usd Price Per Share0.046+63%0.0170.0170%0.038-56%0.034-51%0.035-52%
Usd Profit---2243403.602-2243403.6020%-1786289.611-20%-1733436.928-23%-1733848.385-23%
Usd Revenue--919313.071919313.0710%1001040.608-8%681451.910+35%764859.254+20%
Usd Total Gains Per Share--0.0050.0050%-0.002+139%0.002+206%0.001+742%
 EOD+6 -2MRQTTM+0 -0YOY+20 -165Y+16 -2010Y+18 -18

4.2. Fundamental Score

Let's check the fundamental score of Biotron Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-18.341
Price to Book Ratio (EOD)Between0-120.192
Net Profit Margin (MRQ)Greater than0-2.440
Operating Margin (MRQ)Greater than0-3.520
Quick Ratio (MRQ)Greater than14.193
Current Ratio (MRQ)Greater than14.218
Debt to Asset Ratio (MRQ)Less than10.233
Debt to Equity Ratio (MRQ)Less than10.303
Return on Equity (MRQ)Greater than0.15-1.101
Return on Assets (MRQ)Greater than0.05-0.845
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Biotron Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.512
Ma 20Greater thanMa 500.075
Ma 50Greater thanMa 1000.079
Ma 100Greater thanMa 2000.088
OpenGreater thanClose0.072
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets4,135
Total Liabilities962
Total Stockholder Equity3,173
 As reported
Total Liabilities 962
Total Stockholder Equity+ 3,173
Total Assets = 4,135

Assets

Total Assets4,135
Total Current Assets4,031
Long-term Assets104
Total Current Assets
Cash And Cash Equivalents 3,984
Net Receivables 23
Other Current Assets 24
Total Current Assets  (as reported)4,031
Total Current Assets  (calculated)4,031
+/-0
Long-term Assets
Property Plant Equipment 50
Long-term Assets Other 54
Long-term Assets  (as reported)104
Long-term Assets  (calculated)104
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities956
Long-term Liabilities7
Total Stockholder Equity3,173
Total Current Liabilities
Short-term Debt 39
Accounts payable 285
Other Current Liabilities 632
Total Current Liabilities  (as reported)956
Total Current Liabilities  (calculated)956
+/-0
Long-term Liabilities
Long term Debt Total 7
Long-term Liabilities  (as reported)7
Long-term Liabilities  (calculated)7
+/- 0
Total Stockholder Equity
Common Stock56,890
Retained Earnings -55,264
Accumulated Other Comprehensive Income 1,546
Capital Surplus 1,527
Other Stockholders Equity -1,627
Total Stockholder Equity (as reported)3,173
Total Stockholder Equity (calculated)3,073
+/- 100
Other
Capital Stock56,890
Cash and Short Term Investments 3,984
Common Stock Shares Outstanding 820,842
Current Deferred Revenue-39
Liabilities and Stockholders Equity 4,135
Net Debt -3,939
Net Invested Capital 3,173
Net Tangible Assets 3,173
Net Working Capital 3,076
Property Plant and Equipment Gross 867
Short Long Term Debt Total 45



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-30
> Total Assets 
42,221
10,192
8,633
5,909
3,109
2,429
4,814
1,519
2,267
1,064
1,858
2,645
8,462
4,866
1,864
4,616
3,483
2,060
1,619
5,857
7,826
4,327
1,906
4,135
4,1351,9064,3277,8265,8571,6192,0603,4834,6161,8644,8668,4622,6451,8581,0642,2671,5194,8142,4293,1095,9098,63310,19242,221
   > Total Current Assets 
11,021
9,924
8,110
5,518
2,748
2,204
4,669
1,426
2,152
996
1,814
2,613
8,439
4,843
1,799
4,568
3,446
2,030
1,601
5,777
7,719
4,262
1,762
4,031
4,0311,7624,2627,7195,7771,6012,0303,4464,5681,7994,8438,4392,6131,8149962,1521,4264,6692,2042,7485,5188,1109,92411,021
       Cash And Cash Equivalents 
11,021
9,713
7,577
5,375
2,618
2,113
4,624
1,379
2,064
951
1,781
2,145
7,892
4,792
1,764
4,523
3,418
1,987
1,543
5,740
7,661
4,211
1,741
3,984
3,9841,7414,2117,6615,7401,5431,9873,4184,5231,7644,7927,8922,1451,7819512,0641,3794,6242,1132,6185,3757,5779,71311,021
       Short-term Investments 
0
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000001000
       Net Receivables 
0
111
413
67
66
46
5
41
59
28
9
453
504
2
0
10
0
0
0
0
0
0
0
23
2300000001002504453928594154666674131110
       Other Current Assets 
0
-100
30
10
0
7
19
6
25
15
15
15
15
15
15
15
15
21
58
37
58
51
21
24
24215158375821151515151515151525619701030-1000
   > Long-term Assets 
31,200
268
522
391
362
224
145
93
115
67
44
32
23
24
65
48
37
29
18
80
107
65
144
104
1041446510780182937486524233244671159314522436239152226831,200
       Property Plant Equipment 
0
268
522
391
362
224
143
93
115
67
44
32
23
24
65
48
37
29
18
46
73
31
90
50
509031734618293748652423324467115931432243623915222680
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34
34
0
0
0
00034340000000000000000000
       Intangible Assets 
31,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000031,200
       Other Assets 
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
34
34
0
0
0
00034340000000000002000000
> Total Liabilities 
22
111
143
148
153
150
318
163
424
222
140
244
192
391
475
473
346
620
338
418
853
464
814
962
96281446485341833862034647347539119224414022242416331815015314814311122
   > Total Current Liabilities 
22
111
143
148
153
150
318
163
424
222
140
244
192
391
475
473
346
620
338
412
841
451
751
956
95675145184141233862034647347539119224414022242416331815015314814311122
       Short-term Debt 
0
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41
41
6
34
39
393464141000000000000000001000
       Accounts payable 
0
0
0
0
0
0
0
0
227
35
32
89
28
174
267
249
92
344
136
158
310
138
311
285
285311138310158136344922492671742889323522700000000
       Other Current Liabilities 
22
-100
5
148
32
31
47
45
106
86
78
104
139
172
179
190
230
252
202
254
490
307
405
632
6324053074902542022522301901791721391047886106454731321485-10022
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
12
12
63
7
763121260000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
43
7
7430300000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
9
12
20
0
02012960000000000000000000
> Total Stockholder Equity
42,221
10,081
8,490
5,761
2,956
2,279
4,496
1,356
1,843
842
1,718
2,400
8,270
4,475
1,389
4,143
3,137
1,440
1,282
5,439
6,973
3,863
1,092
3,173
3,1731,0923,8636,9735,4391,2821,4403,1374,1431,3894,4758,2702,4001,7188421,8431,3564,4962,2792,9565,7618,49010,08142,221
   Common Stock
11,163
11,417
11,445
11,445
11,445
12,651
16,865
16,865
19,146
19,921
20,751
23,088
32,549
32,549
32,549
37,208
39,163
40,325
41,439
47,523
52,844
52,844
52,844
56,890
56,89052,84452,84452,84447,52341,43940,32539,16337,20832,54932,54932,54923,08820,75119,92119,14616,86516,86512,65111,44511,44511,44511,41711,163
   Retained Earnings -55,264-51,837-49,087-45,945-42,369-40,757-39,164-36,887-34,405-31,681-28,596-24,745-22,859-21,311-19,439-17,663-15,806-12,620-10,483-8,600-5,795-3,066-1,422-142
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
285
0
0
0
1,527
1,5270002850000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
31,200
91
342
0
0
0
0
0
0
0
0
0
0
0
522
522
43
74
85
285
-6,899
-3,757
-1,007
-1,627
-1,627-1,007-3,757-6,899285857443522522000000000003429131,200



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.